Status:
COMPLETED
Clinical Trial on the Effects of Caffeine and Taurine From Energy Drinks (EDs) to Parameters of the Cardiovascular System in Humans
Lead Sponsor:
University of Hohenheim
Conditions:
Cardiovascular Risk
Eligibility:
All Genders
18-25 years
Phase:
NA
Brief Summary
The aim of this study is to examine the safety and the effects of EDs at high doses, either alone or in combination with other risk factors such as alcohol intake, physical exercise and sleep deprivat...
Eligibility Criteria
Inclusion
- written informed consent
- healthy (no acute or chronic desease)
- BMI 20,0 - 25,9 kg/m2
- moderate and non-regular consumption of alcohol, EDs and coffee
Exclusion
- pregnancy
- regular medication (oral contraceptives permitted)
- hypertension and other deseases of the cardiovascular system
- liver-deseases
- psychiatric deseases
- epilepsy
- other relevant deseases
- (former) alcoholics
- non-compliance to the study-protocol
- simultaneous participation in another clinical trial
- retraction of the written informed consent
Key Trial Info
Start Date :
April 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2013
Estimated Enrollment :
38 Patients enrolled
Trial Details
Trial ID
NCT01421979
Start Date
April 1 2011
End Date
August 1 2013
Last Update
February 5 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Hohenheim
Stuttgart, Baden-Wurttemberg, Germany, 70593